help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-1427
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Justesen, J.
Right arrow Articles by Kassem, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Justesen, J.
Right arrow Articles by Kassem, M.
Endocrinology Vol. 145, No. 4 1916-1925
Copyright © 2004 by The Endocrine Society

Mice Deficient in 11ß-Hydroxysteroid Dehydrogenase Type 1 Lack Bone Marrow Adipocytes, but Maintain Normal Bone Formation

Jeannette Justesen, Lis Mosekilde, Megan Holmes, Karin Stenderup, Jürg Gasser, John J. Mullins, Jonathan R. Seckl and Moustapha Kassem

University Department of Endocrinology and Metabolism, University Hospital of Aarhus (J.J., K.S., M.K.), and Department of Cell Biology, Institute of Anatomy, University of Aarhus (L.M.), DK-8000 Aarhus, Denmark; University Hospital of Odense (M.K.), DK-5000 Odense, Denmark; Molecular Medicine Center, Western General Hospital (M.H., J.J.M., J.R.S.), Edinburgh EH4 2XU, Scotland, United Kingdom; and Novartis Pharma AG (J.G.), CH-4057 Basel, Switzerland

Address all correspondence and requests for reprints to: Dr. Moustapha Kassem, University Department of Endocrinology, University Hospital of Odense, DK-5000 Odense, Denmark. E-mail: mkassem{at}dadlnet.dk.

Glucocorticoids (GCs) exert potent, but poorly characterized, effects on the skeleton. The cellular activity of GCs is regulated at a prereceptor level by 11ß-hydroxysteroid dehydrogenases (11ßHSDs). The type 1 isoform, which predominates in bone, functions as a reductase in intact cells and regenerates active cortisol (corticosterone) from circulating inert 11-keto forms. The aim of the present study was to investigate the role of this intracrine activation of GCs on normal bone physiology in vivo using mice deficient in 11ßHSD1 (HSD1-/-). The HSD1-/- mice exhibited no significant changes in cortical or trabecular bone mass compared with wild-type (Wt) mice. Aged HSD1-/- mice showed age-related bone loss similar to that observed in Wt mice. Histomorphometric analysis showed similar bone formation and bone resorption parameters in HSD1-/- and Wt mice. However, examination of bone marrow composition revealed a total absence of marrow adipocytes in HSD1-/- mice. Cells from Wt and HSD1-/- mice exhibited similar growth rates as well as similar levels of production of osteoblastic markers. The adipocyte-forming capacity of in vitro cultured bone marrow stromal cells and trabecular osteoblasts was similar in HSD1-/- and Wt mice. In conclusion, our results suggest that 11ßHSD1 amplification of intracellular GC actions in mice may be required for bone marrow adipocyte formation, but not for bone formation. The clinical relevance of this observation remains to be determined.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
G. Trudel, M. Payne, B. Madler, N. Ramachandran, M. Lecompte, C. Wade, G. Biolo, S. Blanc, R. Hughson, L. Bear, et al.
Bone marrow fat accumulation after 60 days of bed rest persisted 1 year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study
J Appl Physiol, August 1, 2009; 107(2): 540 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. L. W. Yau, K. M. McNair, J. Noble, D. Brownstein, C. Hibberd, N. Morton, J. J. Mullins, R. G. M. Morris, S. Cobb, and J. R. Seckl
Enhanced Hippocampal Long-Term Potentiation and Spatial Learning in Aged 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Knock-Out Mice
J. Neurosci., September 26, 2007; 27(39): 10487 - 10496.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Grey, M. Bolland, G. Gamble, D. Wattie, A. Horne, J. Davidson, and I. R. Reid
The Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone Decreases Bone Formation and Bone Mineral Density in Healthy Postmenopausal Women: A Randomized, Controlled Trial
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1305 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Paterson, J. R. Seckl, and J. J. Mullins
Genetic manipulation of 11{beta}-hydroxysteroid dehydrogenases in mice
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R642 - R652.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Eijken, M. Hewison, M. S. Cooper, F. H. de Jong, H. Chiba, P. M. Stewart, A. G. Uitterlinden, H. A. P. Pols, and J. P. T. M. van Leeuwen
11{beta}-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation
Mol. Endocrinol., March 1, 2005; 19(3): 621 - 631.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society